Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques
Rev Rhum Ed Fr
.
2022 May;89(3):313-314.
doi: 10.1016/j.rhum.2021.10.560.
Epub 2021 Oct 21.
[Article in French]
Authors
Pascal Richette
1
2
,
Matthieu Allez
3
,
Vincent Descamps
4
,
Lucas Perray
5
,
Simon Pilet
5
,
Augustin Latourte
1
2
,
Milka Maravic
5
Affiliations
1
Rheumatology department, Lariboisière Hospital, AP-HP, Paris, France.
2
Inserm U1132, Paris University, Paris, France.
3
Gastro Enterology department, St-Louis Hospital, AP-HP, Paris, France.
4
Dermatology department, Bichat Hospital, AP-HP, Paris, France.
5
IQVIA, La Défense, France.
PMID:
34697532
PMCID:
PMC8529531
DOI:
10.1016/j.rhum.2021.10.560
No abstract available